My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BrightSpire Capital, Inc. Class A Common Stock (NY:BRSP)

5.420 -0.040 (-0.73%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BrightSpire Capital, Inc. Class A Common Stock

< Previous 1 2 3 4 5 Next >

Looking Into BrightSpire Capital's Return On Capital Employed ↗

May 09, 2023

Via Benzinga

BrightSpire Capital: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

BrightSpire Capital, Inc. Announces First Quarter 2023 Financial Results

May 03, 2023

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital, Inc. Announces First Quarter 2023 Earnings Results and Conference Call Date

April 05, 2023

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital Announces $0.20 Per Share Dividend for First Quarter 2023

March 16, 2023

From BrightSpire Capital, Inc.

Via Business Wire

Looking Into BrightSpire Capital's Return On Capital Employed ↗

February 22, 2023

Via Benzinga

BrightSpire Capital, Inc. Announces 2023 Annual Meeting of Stockholders

March 10, 2023

From BrightSpire Capital, Inc.

Via Business Wire

The Best-Performing Mortgage REITs In 2023 ↗

March 03, 2023

Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 01, 2023

It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 01, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

BrightSpire Capital, Inc. Prices Secondary Offering by DigitalBridge Group, Inc.

February 28, 2023

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital, Inc. Announces Secondary Offering of 30,358,213 Shares of Class A Common Stock by DigitalBridge Group, Inc.

February 28, 2023

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital, Inc. Announces Fourth Quarter & Full Year 2022 Financial Results

February 21, 2023

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital, Inc.; Tax Treatment of 2022 Dividends

February 06, 2023

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital, Inc. Announces Fourth Quarter and Full Year 2022 Earnings Results and Conference Call Date

January 23, 2023

From BrightSpire Capital, Inc.

Via Business Wire

A Look Into Real Estate Sector Value Stocks ↗

January 16, 2023

Via Benzinga

BrightSpire Capital Announces $0.20 Per Share Dividend for Fourth Quarter 2022

December 14, 2022

From BrightSpire Capital, Inc.

Via Business Wire

These 3 Mortgage REITs Have Yields Of Over 13% And Are Trading For Far Less Than They're Worth ↗

November 19, 2022

The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

BrightSpire Capital: Q3 Earnings Insights ↗

November 02, 2022

BrightSpire Capital (NYSE:BRSP) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings BrightSpire Capital...

Via Benzinga

BrightSpire Capital, Inc. Announces Third Quarter 2022 Financial Results

November 02, 2022

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital, Inc. Announces Third Quarter 2022 Earnings Results and Conference Call Date

October 04, 2022

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital Announces $0.20 Per Share Dividend for Third Quarter 2022

September 15, 2022

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital: Q2 Earnings Insights ↗

August 03, 2022

BrightSpire Capital (NYSE:BRSP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

BrightSpire Capital, Inc. Announces Second Quarter 2022 Financial Results

August 03, 2022

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital, Inc. Announces Second Quarter 2022 Earnings Results and Conference Call Date

July 05, 2022

From BrightSpire Capital, Inc.

Via Business Wire

BrightSpire Capital Announces $0.20 Per Share Dividend for Second Quarter 2022

June 15, 2022

From BrightSpire Capital, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.